Stock Information
Latest News
News Functions
Additional Functions
9 July 2015
Karolinska Development AB
Karolinska Development divests its holding in Pharmanest to an investment consortium comprising Östersjöstiftelsen, Recipharm Venture Fund and Praktikerinvest
Karolinska Development AB
Karolinska Development implements a more prudent and representative approach to reporting the fair value of its portfolio – divestment of Pharmanest
28 April 2015
Karolinska Development AB
Karolinska Development announces preliminary portfolio valuation for the January-March 2015 Interim Report
20 April 2015
Karolinska Development AB
Aprea presents preliminary clinical Phase Ib/II results in ovarian cancer at AACR with APR-246 – a novel candidate drug that restores mutant p53 protein into its wild-type function
27 March 2015
Karolinska Development AB
Clanotech granted Orphan Drug Designation by the U.S. FDA
Karolinska Development AB
Karolinska Development sells its stake in Axelar to Östersjöstiftelsen